FDA calendar: PDUFA and other FDA dates, and biotech catalysts.
The FDA decision dates, advisory committee meetings, and trial data dates drug companies have announced, with a countdown to each. The dates are the ones the companies have said in their SEC filings, and the trial registry's. They often move, and a date a company never filed is not here.
The next FDA dates
Soonest first, and small companies first: those under $5 billion with no drug on sale yet.
- In 28 daysINOInovio Pharmaceuticals
INOINO-3107
- In 39 daysNRXPNRX Pharmaceuticals
NRXPDrug not named
- In 51 daysCAPRCapricor Therapeutics
CAPRDrug not named
What these dates are
- PDUFA date
- The date by which the FDA has said it aims to decide on a company's application to sell a drug. The FDA can decide earlier, or extend the date.
- ANDA decision date
- The same kind of goal date for a generic drug's application (an ANDA), set under the generic drug program (GDUFA), not PDUFA.
- Advisory committee
- Outside experts meet in public to advise the FDA on an application. The FDA does not have to follow their vote.
- Trial data date
- The date the trial registry lists for a trial's last main measurement, as the sponsor estimates it. Results usually follow weeks to months later.
Every stock here has its own page with its trials, its cash runway, and its insiders' trades, like Inovio Pharmaceuticals (INO). Browse more drug makers on the healthcare stocks page.
The full list, with the cash behind each date.
The full list with filters by area, phase, size, and date, each company's cash runway against its date, its past reactions, and optional alerts a week before and on the day.
Free for 24 hours. No account needed. Then keep going with a free account.